Rslcan-10 inhibitors are a class of small molecules that specifically target and inhibit the function of the Rslcan-10 protein, a key regulator involved in various cellular processes. The structure of these inhibitors is typically characterized by complex organic frameworks that include functional groups capable of forming strong interactions with the binding sites of Rslcan-10. These interactions are often mediated by hydrogen bonds, π-π stacking, or hydrophobic contacts, ensuring a high degree of specificity and affinity toward the target protein. The design of Rslcan-10 inhibitors is based on structural studies of the protein's active site, with particular attention to conformational flexibility and the ability to adopt different binding poses, allowing for greater inhibition efficiency. Researchers use advanced computational techniques like molecular docking and dynamics simulations to refine these compounds, optimizing their fit within the active site of Rslcan-10.
Inhibitors of Rslcan-10 are studied extensively in cellular assays to understand their impact on signaling pathways, enzymatic activity, and the regulation of downstream proteins. By blocking the activity of Rslcan-10, these inhibitors allow researchers to probe the role of this protein in fundamental biological mechanisms such as cell cycle regulation, protein-protein interactions, and transcriptional modulation. Additionally, they provide a tool for investigating the structural dynamics of Rslcan-10 itself, offering insights into the conformational changes that occur upon inhibitor binding. The chemical diversity of Rslcan-10 inhibitors permits the exploration of structure-activity relationships, giving rise to a deeper understanding of how modifications to chemical scaffolds influence inhibitory potential and specificity. These studies contribute to the broader knowledge of Rslcan-10's function within various biochemical networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methylation, potentially affecting the expression of genes regulated by zinc finger proteins like ZNF455. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, which may affect the transcriptional regulation of genes involving zinc finger proteins like ZNF455. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor, potentially influencing the transcriptional activity of zinc finger proteins. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Can bind to copper ions, potentially disrupting the function of copper-dependent enzymes and may indirectly affect zinc finger proteins. | ||||||
PI3K/HDAC Inhibitor | 1339928-25-4 | sc-364584 sc-364584A | 5 mg 10 mg | $340.00 $462.00 | ||
A dual inhibitor of HDAC and PI3K, potentially influencing the regulation of gene expression and pathways involving ZNF455. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to GC-rich DNA sequences, potentially disrupting the DNA binding of certain zinc finger proteins. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Another DNA methyltransferase inhibitor, potentially affecting the expression of genes regulated by ZNF455. | ||||||